1
siRNA -24 hrs Thymidine Release siRNA Thymidine 0 Release -39 hrs -20 hrs -15 hrs -44 hrs 9 hrs Mitosis ± Reversine 0.5 μM or AZ3146 2 μM 15 hrs Wash-out 15 hrs 5 hrs 4 hrs 5 hrs 15 hrs Bub1 RNAi Mad2 RNAi Rev 0.5μM AZ 2μM Ctrl 100 KDa 37 20 15 WB 33 hrs 0 Drug Treatment Bub1 RNAi Mad2 RNAi Rev 0.5μM AZ 2μM Ctrl WB 57 hrs 0 Drug Treatment LC3-I LC3-II Mad2 Actin Bub1 B A 100 KDa 37 siRNA Ctrl Bub1 Mad2 20 15 LC3-I LC3-II Mad2 Actin Bub1 Ctrl Bub1 Mad2 + ZM447439 C D IMR-90 15 KDa 37 Actin Ctrl Rev LC3-I LC3-II Lymphoblastoid 15 KDa 100 Vinculin Ctrl Rev LC3-I LC3-II LC3-I LC3-II Actin Ctrl Rev AZ BJ-hTERT 15 KDa 37 E F Santaguida_Supplemental Figure 3

Supplemental Figure 2 - Genes & Developmentgenesdev.cshlp.org/.../gad.269118.115.DC1/SuppFigure_3.pdf2015/09/22  · Santaguida_Supplemental Figure 3 Title Supplemental Figure 2 Created

  • Upload
    others

  • View
    8

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Supplemental Figure 2 - Genes & Developmentgenesdev.cshlp.org/.../gad.269118.115.DC1/SuppFigure_3.pdf2015/09/22  · Santaguida_Supplemental Figure 3 Title Supplemental Figure 2 Created

siRNA

-24 hrs

Thymidine Release siRNA Thymidine

0

Release

-39 hrs -20 hrs -15 hrs-44 hrs 9 hrs

Mitosis

± Reversine 0.5 µMor AZ3146 2 µM

15 hrs

Wash-out15 hrs5 hrs 4 hrs 5 hrs 15 hrs

Bub1RNAi

Mad2RNAi

Rev0.5µM

AZ2µMCtrl

100 KDa

37

20

15

WB

33 hrs0

Drug Treatment

Bub1RNAi

Mad2RNAi

Rev0.5µM

AZ2µMCtrl

WB

57 hrs0

Drug Treatment

LC3-ILC3-II

Mad2

Actin

Bub1

B

A

100 KDa

37

siRNA Ctrl Bub1 Mad2

20

15 LC3-ILC3-II

Mad2

Actin

Bub1Ctrl Bub1 Mad2+ ZM447439

C

DIMR-90

15 KDa

37 Actin

Ctrl RevLC3-ILC3-II

Lymphoblastoid

15 KDa

100 Vinculin

Ctrl RevLC3-ILC3-II

LC3-ILC3-II

Actin

Ctrl Rev AZBJ-hTERT

15 KDa

37

E

F

Santaguida_Supplemental Figure 3